Bristol Myers Squibb Performance

The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Bristol Myers are completely uncorrelated.

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Bristol Myers Squibb has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable primary indicators, Bristol Myers is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors. ...more
Begin Period Cash Flow15 B
Total Cashflows From Investing Activities-538 M
  

Bristol Myers Relative Risk vs. Return Landscape

If you would invest (100.00) in Bristol Myers Squibb on December 29, 2023 and sell it today you would earn a total of  100.00  from holding Bristol Myers Squibb or generate -100.0% return on investment over 90 days. Bristol Myers Squibb is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Bristol, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  

Bristol Myers Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Bristol Myers' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Bristol Myers Squibb, and traders can use it to determine the average amount a Bristol Myers' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
BMYMP
Based on monthly moving average Bristol Myers is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bristol Myers by adding Bristol Myers to a well-diversified portfolio.

Bristol Myers Fundamentals Growth

Bristol Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Bristol Myers, and Bristol Myers fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bristol Pink Sheet performance.

Things to note about Bristol-Myers Squibb performance evaluation

Checking the ongoing alerts about Bristol Myers for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Bristol-Myers Squibb help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Bristol-Myers Squibb is not yet fully synchronised with the market data
Bristol-Myers Squibb has some characteristics of a very speculative penny stock
Bristol-Myers Squibb has a very high chance of going through financial distress in the upcoming years
Evaluating Bristol Myers' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Bristol Myers' pink sheet performance include:
  • Analyzing Bristol Myers' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bristol Myers' stock is overvalued or undervalued compared to its peers.
  • Examining Bristol Myers' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Bristol Myers' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bristol Myers' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Bristol Myers' pink sheet. These opinions can provide insight into Bristol Myers' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Bristol Myers' pink sheet performance is not an exact science, and many factors can impact Bristol Myers' pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Consideration for investing in Bristol Pink Sheet

If you are still planning to invest in Bristol-Myers Squibb check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bristol Myers' history and understand the potential risks before investing.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets